go back

Lisocabtagene Maraleucel (Breyanzi)

New Jersey rates for HCPCS C9076

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $13,490 · 10th–90th $135$29,5120%10%10th90th$13,490Professionalmedian $416,869 · 10th–90th $416,869$416,8690%50%$416,869$100.0$500.0$2.0K$10.0K$50.0K$200.0K$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Horizon BCBS
Setting
Facility
Modifier
Global
Typical Low
$134.90
Median
$13,489.63
Typical High
$29,512.09
Horizon BCBS
Setting
Professional
Modifier
Global
Typical Low
$416,869.38
Median
$416,869.38
Typical High
$416,869.38
United
Setting
Facility
Modifier
Global
Typical Low
$512,861.38
Median
$512,861.38
Typical High
$512,861.38
United
Setting
Professional
Modifier
Global
Typical Low
$537,031.80
Median
$537,031.80
Typical High
$537,031.80